Skip to content

    Vaxcyte (PCVX) stock price & financials

    View PCVX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+95.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$139.92M
    -$162.17M
    -$180.79M
    -$226.22M
    -$242.38M
    -73.2%
    -$274.28M
    -69.1%
    -$345.85M
    -91.3%
    -$302.78M
    -33.8%
    Weakening
    Net Profit
    -$103.12M
    -$137.08M
    -$140.72M
    -$166.57M
    -$212.83M
    -106.4%
    -$246.51M
    -79.8%
    -$320.62M
    -127.8%
    -$284.30M
    -70.7%
    Weakening
    EPS
    $-0.83
    $-1.04
    $-1.22
    $-1.56
    -88.0%
    $-2.30
    -121.2%
    $-1.97
    -61.5%
    Weakening
    Other Income
    $36.80M
    $25.09M
    $40.08M
    $59.65M
    $29.55M
    -19.7%
    $27.78M
    +10.7%
    $25.23M
    -37.0%
    $18.48M
    -69.0%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    3.7%
    5.0%
    5.1%
    6.0%
    7.7%
    +106.4%
    8.9%
    +79.8%
    11.6%
    +127.8%
    10.3%
    +70.7%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$66.09M$58.98M$386.20M$68.98M$834.66M$397.45M$387.88M$173.96M$183.19M
    Short-Term Investments
    Total Current Assets$61.72M$389.00M$256.35M$942.55M$1.10B$1.79B$1.63B$1.55B
    Net PP&E$3.39M$3.27M$35.91M$31.65M$110.62M$270.15M$373.38M$370.57M
    Goodwill
    Intangibles
    Total Assets$65.70M$392.83M$324.34M$1.01B$1.41B$3.51B$3.00B$3.14B
    LiabilitiesTotal Current Liabilities$11.05M$46.86M$28.72M$40.52M$145.34M$140.18M$205.75M$271.28M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$11.51M$12.03M$22.11M$65.22M$111.46M$108.94M
    Total Liabilities$11.76M$46.98M$40.32M$52.56M$167.45M$205.50M$317.21M$380.21M
    EquityCommon Stock & APIC$7.0K$54.0K$56.0K$82.0K$98.0K$128.0K$134.0K$148.0K
    Retained Earnings-$109.35M-$198.56M-$298.64M-$522.13M-$924.39M-$1.39B-$2.15B-$2.76B
    Total Equity-$57.73M-$106.37M$345.84M$284.02M$953.61M$1.24B$3.31B$2.69B$2.76B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$30.47M-$47.15M-$46.63M-$121.39M-$170.60M-$296.79M-$452.63M-$655.58M-$881.23M
    Cash from Investing-$1.77M-$1.20M-$1.10M-$212.31M$74.58M-$773.31M-$2.01B$437.35M$150.60M
    Cash from Financing$62.19M$41.57M$374.87M$17.80M$861.55M$639.81M$2.45B$2.01M$606.02M
    SummaryCapital Expenditure-$1.77M-$1.20M-$1.16M-$6.55M-$5.84M-$16.06M-$22.43M-$13.71M-$12.90M
    Free Cash Flow-$32.24M-$48.34M-$47.78M-$127.95M-$176.44M-$312.85M-$475.05M-$669.29M-$894.14M
    FCF Margin

    Ratios